Andreotti G, Citro V, Correra A, Cubellis MV
A thermodynamic assay to test pharmacological chaperones for Fabry disease
Bba-Gen Subjects (ISSN: 0925-4439, 0006-3002, 1570-9639), 2014 Mar; 1840(3): 1214-1224.

Cammisa M, Correra A, Andreotti G, Cubellis MV
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
Orphanet Journal Of Rare Diseases (ISSN: 1750-1172), 2013 Jul 24; 8: 111-111.

Andreotti G, Pedone E, Giordano A, Cubellis MV
Biochemical phenotype of a common disease-causing mutation and a possible therapeutic approach for the phosphomannomutase 2-associated disorder of glycosylation
Molecular Genetics & Genomic Medicine (ISSN: 2324-9269), 2013 May; 1(1): 32-44.

Cammisa M, Correra A, Andreotti G, Cubellis MV
Identification and analysis of conserved pockets on protein surfaces
Bmc Bioinformatics (ISSN: 1471-2105), 2013 Apr 22; 14: S9-S9.

Riccio A, Cubellis MV
Gain of function in CDKN1C
Nature Genetics (ISSN: 1061-4036), 2012 Jul; 44(7): 737-738.

Andreotti G, Citro V, De Crescenzo A, Orlando P, Cammisa M, Correra A, Cubellis MV
Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests
Orphanet Journal Of Rare Diseases (ISSN: 1750-1172), 2011 Oct 17; 6: 66-66.

Andreotti G, Guarracino MR, Cammisa M, Correra A, Cubellis MV
Prediction of the responsiveness to pharmacological chaperones: lysosomal human alpha-galactosidase, a case of study
Orphanet Journal Of Rare Diseases (ISSN: 1750-1172), 2010 Dec 8; 5: 36-36.